Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Intensified Salvage Radiotherapy in Biochemically Relapsed Prostate Cancer Without Macroscopic Disease. A Randomized Phase III Trial.

NCT01272050 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.

NCT NCT01272050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01272050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Intensified Salvage Radiotherapy in Biochemically Relapsed Prostate Cancer Without Macroscopic Disease. A Randomized Phase III Trial.
Lead sponsor
Swiss Cancer Institute
Phase
Phase 3
Overall status
Completed
Start date
January 6, 2011
Completion date
May 31, 2024
Enrollment
350 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer